Physician profile
Erica L Haake
NPI 1033264585
$9,628.58
in general payments reported to CMS, 2019-2025
30 companies · $3,183 in 2025
The $3,183 reported for 2025 was more than what 96% of Obstetrics providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $213 · 2020: $111 · 2021: $163 · 2022: $52.52 · 2023: $123 · 2024: $5,783 · 2025: $3,183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $8,542 · Food and Beverage: $398 · Consulting Fee: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $8,542.00 |
| Food and Beverage | $397.73 |
| Consulting Fee | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $8,565.56 | 2024-2025 | Nexplanon |
| Abbvie INC. | $263.28 | 2019-2021 | |
| Pfizer INC. | $183.38 | 2020-2024 | |
| Astellas Pharma US INC | $81.79 | 2019-2025 | Veozah, Myrbetriq |
| Biogen, INC. | $49.99 | 2025 | Zurzuvae |
| Merck Sharp & Dohme LLC | $47.43 | 2024 | Gardasil, Gardasil 9, Vaxneuvance |
| Sumitomo Pharma America, INC. | $42.73 | 2023-2024 | Myfembree |
| C. R. Bard, INC. & Subsidiaries | $36.77 | 2023 | Bard Urinary Drainage Bag |
| Intuitive Surgical, INC. | $34.85 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.26 | 2024-2025 | |
| Sobi, INC | $30.84 | 2021-2023 | |
| Alydia Health | $28.76 | 2021 | |
| Glaxosmithkline, LLC. | $24.39 | 2020-2021 | |
| Corium, LLC | $22.61 | 2022 | |
| Novo Nordisk INC | $20.96 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $20.55 | 2024 | Aptima |
| Teleflex LLC | $17.96 | 2025 | Quikclot |
| Myovant Sciences INC. | $17.92 | 2022 | |
| Seqirus USA INC | $16.42 | 2024 | Flucelvax |
| Ultragenyx Pharmaceutical INC. | $15.23 | 2023 | |
| Sanofi Pasteur INC. | $14.90 | 2021 | |
| Dexcom, INC. | $14.14 | 2023 | Dexcom G6 Transmitter |
| Daiichi Sankyo INC. | $11.99 | 2022 | |
| Amgen INC. | $11.80 | 2020 | |
| Allergan, INC. | $11.54 | 2020 | |
| Lilly USA, LLC | $11.53 | 2020 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erica Haake listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.